Journal article
Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
- Abstract:
-
BACKGROUND: Only one-third of patients with depression respond fully to treatment with antidepressant medication. However, there is little robust evidence to guide the management of those whose symptoms are 'treatment resistant'. OBJECTIVE: The CoBalT trial examined the clinical effectiveness and cost-effectiveness of cognitive behavioural therapy (CBT) as an adjunct to usual care (including pharmacotherapy) for primary care patients with treatment-resistant depression (TRD) compared with usu...
Expand abstract
Actions
Authors
Bibliographic Details
- Publisher:
- National Co-ordinating Centre for HTA
- Journal:
- Health technology assessment (Winchester, England)
- Volume:
- 18
- Issue:
- 31
- Pages:
- 1-viii
- Publication date:
- 2014-05-01
- DOI:
- EISSN:
-
2046-4924
- ISSN:
-
1366-5278
- Source identifiers:
-
491198
Item Description
- Language:
- English
- Pubs id:
-
pubs:491198
- UUID:
-
uuid:08c2dfa9-097a-49fd-a284-11dae00f63a8
- Local pid:
- pubs:491198
- Deposit date:
- 2014-12-10
Terms of use
- Copyright date:
- 2014
If you are the owner of this record, you can report an update to it here: Report update to this record